← Insider buys
EWTX

Edgewise Therapeutics, Inc. · Healthcare

Chief Business Officer Behrad Derakhshan sold $223K of Edgewise Therapeutics, Inc.

Sold$223,424
$43.81Price
5,100Shares
−14%Stake

What EWTX did after the filing

Filed Aug 14Copier in Aug 18
The stock from Tue, Aug 18 open, $43.17
+3.1%
S&P 500, same days
+0.6%

24 of 30 trading days so far, to the Sep 22 close.

Traded Wed, Aug 12. Filed Fri, Aug 14, 4:53 PM ET, after the close. Returns use the Aug 18 open and the Sep 22 close. Not investment advice.